Fate Therapeutics, Inc.

Halal Rating :
See Details
Last Price $3.41 Last updated:
Market Cap $392.72m
7D Change 0.0%
1 Year Change 0.0%

Company Overview

  • Health Technology
  • Biotechnology
  • Manufacturing
  • Biological Product (except Diagnostic) Manufacturing
Exchange NASDAQ
Next Earnings Date Feb. 28, 2024

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders globally. The company is headquartered in San Diego, California.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
March 31, 2024 $2.2m $73.85m $4.15m - 188.76% 0.00%
Dec. 31, 2023 $1.95m $77.4m $4.41m $9.71m 226.48% 12.55%
Sept. 30, 2023 $2.22m $72.17m $4.7m - 211.86% 0.00%

Company Impact

Help us evaluate Fate Therapeutics, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Justification for our Halal Rating

Recent News & Updates